Full Text View
Tabular View
No Study Results Posted
Related Studies
gB/MF59 Vaccine in Preventing Cytomegalovirus Infection in Healthy Adolescent Females
This study is ongoing, but not recruiting participants.
Study NCT00133497   Information provided by National Institute of Allergy and Infectious Diseases (NIAID)

First Received on August 19, 2005.   Last Updated on March 28, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cytomegalovirus Infections
More general conditions related to this trial
DNA Virus Infections
Herpesviridae Infections
Virus Diseases
Interventions listed in this trial
CMV gB vaccine
Placebo
MF-59
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services